scholarly journals An Insight into the Secondary Metabolism of Muscodor yucatanensis: Small-Molecule Epigenetic Modifiers Induce Expression of Secondary Metabolism-Related Genes and Production of New Metabolites in the Endophyte

2016 ◽  
Vol 73 (4) ◽  
pp. 954-965 ◽  
Author(s):  
Masroor Qadri ◽  
Yedukondalu Nalli ◽  
Shreyans K. Jain ◽  
Asha Chaubey ◽  
Asif Ali ◽  
...  
Marine Drugs ◽  
2020 ◽  
Vol 18 (8) ◽  
pp. 407 ◽  
Author(s):  
Björn Marcus von Reumont ◽  
Tim Lüddecke ◽  
Thomas Timm ◽  
Günter Lochnit ◽  
Andreas Vilcinskas ◽  
...  

Nemerteans (ribbon worms) employ toxins to subdue their prey, but research thus far has focused on the small-molecule components of mucus secretions and few protein toxins have been characterized. We carried out a preliminary proteotranscriptomic analysis of putative toxins produced by the hoplonemertean Amphiporus lactifloreus (Hoplonemertea, Amphiporidae). No variants were found of known nemertean-specific toxin proteins (neurotoxins, cytotoxins, parbolysins or nemertides) but several toxin-like transcripts were discovered, expressed strongly in the proboscis, including putative metalloproteinases and sequences resembling sea anemone actitoxins, crown-of-thorn sea star plancitoxins, and multiple classes of inhibitor cystine knot/knottin family proteins. Some of these products were also directly identified in the mucus proteome, supporting their preliminary identification as secreted toxin components. Two new nemertean-typical toxin candidates could be described and were named U-nemertotoxin-1 and U-nemertotoxin-2. Our findings provide insight into the largely overlooked venom system of nemerteans and support a hypothesis in which the nemertean proboscis evolved in several steps from a flesh-melting organ in scavenging nemerteans to a flesh-melting and toxin-secreting venom apparatus in hunting hoplonemerteans.


2010 ◽  
Vol 51 (2) ◽  
pp. 475-482 ◽  
Author(s):  
Somisetti V. Sambasivarao ◽  
Orlando Acevedo

2015 ◽  
Vol 370 (1677) ◽  
pp. 20140208 ◽  
Author(s):  
Ione Fine ◽  
Geoffrey M. Boynton

An extraordinary variety of sight recovery therapies are either about to begin clinical trials, have begun clinical trials, or are currently being implanted in patients. However, as yet we have little insight into the perceptual experience likely to be produced by these implants. This review focuses on methodologies, such as optogenetics, small molecule photoswitches and electrical prostheses, which use artificial stimulation of the retina to elicit percepts. For each of these technologies, the interplay between the stimulating technology and the underlying neurophysiology is likely to result in distortions of the perceptual experience. Here, we describe some of these potential distortions and discuss how they might be minimized either through changes in the encoding model or through cortical plasticity.


2015 ◽  
Vol 11 (7) ◽  
pp. 2042-2050 ◽  
Author(s):  
Junli Xu ◽  
Zhonghua Wang ◽  
Pi Liu ◽  
Dongmei Li ◽  
Jianping Lin

The binding of small-molecule antagonists, CP-376395 and MTIP, would induce conformational dynamics behaviors of CRF1R.


2014 ◽  
Vol 2014 ◽  
pp. 1-13 ◽  
Author(s):  
Jessica Brunquell ◽  
Jia Yuan ◽  
Aqeela Erwin ◽  
Sandy D. Westerheide ◽  
Bin Xue

Deleted in breast cancer 1 (DBC1, CCAR2, KIAA1967) is a large, predominantly nuclear, multidomain protein that modulates gene expression by inhibiting several epigenetic modifiers, including the deacetylases SIRT1 and HDAC3, and the methyltransferase SUV39H1. DBC1 shares many highly conserved protein domains with its paralog cell cycle and apoptosis regulator 1 (CCAR1, CARP-1). In this study, we examined the full-length sequential and structural properties of DBC1 and CCAR1 from multiple species and correlated these properties with evolution. Our data shows that the conserved domains shared between DBC1 and CCAR1 have similar domain structures, as well as similar patterns of predicted disorder in less-conserved intrinsically disordered regions. Our analysis indicates similarities between DBC1, CCAR1, and the nematode protein lateral signaling target 3 (LST-3), suggesting that DBC1 and CCAR1 may have evolved from LST-3. Our data also suggests that DBC1 emerged later in evolution than CCAR1. DBC1 contains regions that show less conservation across species as compared to the same regions in CCAR1, suggesting a continuously evolving scenario for DBC1. Overall, this study provides insight into the structure and evolution of DBC1 and CCAR1, which may impact future studies on the biological functions of these proteins.


PLoS ONE ◽  
2014 ◽  
Vol 9 (9) ◽  
pp. e107123 ◽  
Author(s):  
Dunia Pino Del Carpio ◽  
Ram Kumar Basnet ◽  
Danny Arends ◽  
Ke Lin ◽  
Ric C. H. De Vos ◽  
...  

2017 ◽  
Vol 31 (1) ◽  
pp. e2674 ◽  
Author(s):  
Neha Tiwari ◽  
Ankit Srivastava ◽  
Bishwajit Kundu ◽  
Manoj Munde

2015 ◽  
Vol 51 (81) ◽  
pp. 15008-15011 ◽  
Author(s):  
Mitchell Hattie ◽  
Tasuku Ito ◽  
Aleksandra W. Debowski ◽  
Takatoshi Arakawa ◽  
Takane Katayama ◽  
...  

Synthesis and structural analysis of rationally developed inhibitors.


2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Shatrujeet Pandey ◽  
Ridhi Goel ◽  
Archana Bhardwaj ◽  
Mehar H. Asif ◽  
Samir V. Sawant ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document